195 related articles for article (PubMed ID: 3010671)
1. Biological actions of prostacyclin and its pharmacological use in platelet studies.
Moncada S; Whittle BJ
Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
[No Abstract] [Full Text] [Related]
2. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
Gorman RR; Wierenga W; Miller OV
Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
[No Abstract] [Full Text] [Related]
3. A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Wright-Schulte Lecture.
Verstraete M
Haemostasis; 1982; 12(4):317-36. PubMed ID: 6295896
[TBL] [Abstract][Full Text] [Related]
4. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
5. Mode of action of dipyridamole on human platelets.
Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG
Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583
[No Abstract] [Full Text] [Related]
6. Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets.
Best LC; Bone EA; Jones PB; Russell RG
Biochim Biophys Acta; 1980 Oct; 632(2):336-42. PubMed ID: 6251913
[TBL] [Abstract][Full Text] [Related]
7. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
Grodzińska L; Marcinkiewicz E
Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
[No Abstract] [Full Text] [Related]
8. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
Heyns Adu P; Eldor A; Yarom R; Marx G
Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
10. Prostacyclin prolongs viability of washed human platelets.
Blackwell GJ; Radomski M; Vargas JR; Moncada S
Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
[TBL] [Abstract][Full Text] [Related]
11. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
[No Abstract] [Full Text] [Related]
12. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
13. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
[TBL] [Abstract][Full Text] [Related]
15. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
16. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
[TBL] [Abstract][Full Text] [Related]
18. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
19. Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella.
Vargaftig BB; Prado-Franceschi J; Chignard M; Lefort J; Marlas G
Eur J Pharmacol; 1980 Dec; 68(4):451-64. PubMed ID: 7009169
[TBL] [Abstract][Full Text] [Related]
20. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]